Can CD44 Be a Mediator of Cell Destruction? The Challenge of Type 1 Diabetes

Nathalie Assayag-Asherie; Dror Sever; Marika Bogdani; Pamela Johnson; Talya Weiss; Ariel Ginzberg; Sharon Perles; Lola Weiss; Lora Eshkar Sebban; Eva A. Turley; Elimelech Okon; Itamar Raz; David Naor

doi:10.1371/journal.pone.0143589

Loading metrics

Open Access

Peer-reviewed

Research Article

Can CD44 Be a Mediator of Cell Destruction? The Challenge of Type 1 Diabetes

Nathalie Assayag-Asherie,

Affiliation The Lautenberg Center for Immunology and Cancer Research, IMRIC, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel
⨯
Dror Sever,

Affiliation Department of Endocrinology, Hadassah University Hospital, Ein Kerem, Jerusalem 91120, Israel
⨯
Marika Bogdani,

Affiliation Matrix Biology Program, Benaroya Research Institute, Seattle, WA, United States of America
⨯
Pamela Johnson,

Affiliation Matrix Biology Program, Benaroya Research Institute, Seattle, WA, United States of America
⨯
Talya Weiss,

Affiliation The Lautenberg Center for Immunology and Cancer Research, IMRIC, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel
⨯
Ariel Ginzberg,

Affiliation The Lautenberg Center for Immunology and Cancer Research, IMRIC, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel
⨯
Sharon Perles,

Affiliation The Lautenberg Center for Immunology and Cancer Research, IMRIC, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel
⨯
Lola Weiss,

Affiliation Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah University Hospital Ein Kerem, Hebrew University, Jerusalem, 91120 Israel
⨯
Lora Eshkar Sebban,

Affiliation The Lautenberg Center for Immunology and Cancer Research, IMRIC, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel
⨯
Eva A. Turley,

Affiliation London Regional Cancer Center, University of Western Ontario, London, ON, Canada
⨯
Elimelech Okon,

Affiliation LEM laboratories Science Park, Rehovot, Israel
⨯
Itamar Raz,

Affiliation Diabetes Unit, Hadassah University Hospital, PO Box 12000, Jerusalem 91120, Israel
⨯
David Naor

* E-mail: davidn@ekmd.huji.ac.il

Affiliation The Lautenberg Center for Immunology and Cancer Research, IMRIC, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel
⨯

Can CD44 Be a Mediator of Cell Destruction? The Challenge of Type 1 Diabetes

Nathalie Assayag-Asherie,
Dror Sever,
Marika Bogdani,
Pamela Johnson,
Talya Weiss,
Ariel Ginzberg,
Sharon Perles,
Lola Weiss,
Lora Eshkar Sebban,
Eva A. Turley

Published: December 1, 2015
https://doi.org/10.1371/journal.pone.0143589

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.
Insulin
Is the Subject Area "Insulin" applicable to this article?

Thanks for your feedback.
Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.
Glucose
Is the Subject Area "Glucose" applicable to this article?

Thanks for your feedback.
Insulin secretion
Is the Subject Area "Insulin secretion" applicable to this article?

Thanks for your feedback.
Nitric oxide
Is the Subject Area "Nitric oxide" applicable to this article?

Thanks for your feedback.
Spleen
Is the Subject Area "Spleen" applicable to this article?

Thanks for your feedback.